Yes, why not keep your money in this dead dog and wait ten months to see if something good happens? It better, because by yearend, they'll be flat broke.
As J.P. was waltzing me around the Hilton ballroom, he kept whispering in my ear, "Ironwood! Ironwood!" That fresh Andrew Carnegie heard him mention "iron" and kept trying to cut in. ( By the way, notice, that unlike Betonbio, I am actually giving the names of my KOL's.)
PS I went to the JP Morgan conference, too ... and J.P. Morgan himself danced with me! Talk about KOL's!!!
Still waiting for any serious rebuttal to these damning facts. As one of those Presidential candidates reminded us, John Adams said, "Facts are stubborn things."
PS The lawyers will contend that there is no way that a price negotiated between Shire and their former employee could be viewed as anything but a sweetheart deal.
Superwow! Thumbs up to this one! I am selling 2,000 of my IRWD shares and buying 200 of those January5 LEAP options for 85 cents apiece! When this reaches 21, my $17,000 investment will reap me a $300,000 profit! (Don't tell the Najarian brothers that I'm about to rip them off.)
Grab those cheap options! This is the opportunity of a lifetime!
I didn't realize that KOLs stood for Key Opinion Leaders. The combination of KOLs and pundits is pretty convincing. By the way, who were those Key Opinion Leaders?
Yeah, he made himself rich, too. But BMY wasn't smiling when that miracle HepC drug flopped in trials, killing one paitent and putting 8 others in the hospital. They wrote off the whole investment 8 months later. As one U of Michigan professor put it, "Bristol Myers paid a fortune for a pearl which turned out to be a fake."
Pundits, too! $20!! What about that big pop that was due on NDA filing? Once again, it's highly flattering that you post this nonsense under an approximation of my id, but highly suspect that you seem ashamed to use your own.
A lot of hope pinned on Shire acquisition. If they had any real hope of such an event, they would NOT hire former Shire employees. Particularly with an ex-Shire CFO, the lawyers would be all over it.
CTRV is headed for the pink sheets. The big success, Inhibitex, flopped in trials as you should know, and BMY wrote off their multi-billion dollar investment. I don't think they'll be in the market for another Cerron biotech soon.
What lies? All facts, Pops. Dispute them if you can. You can't, of course, which is why you post this juvenile nonsense.
No, if they had a better drug, it would have been licensed/partnered by now. SGYP has NO clinical trials underway. Not even a lousy Phase I or II for the much-touted dolcanatide. And the IBS-C trials for plecanatide seem to be inactive. Some pipeline. Sorry, if you find facts annoying - suggest you do as hawk does and block me. After all, why should we read anything that challenges our own opinions? no doub this stock will continue to perform for you in the future as it has for you in the past.
Waiting for something other than silliness, Pops. Wasn't this supposed to skyrocket on the NDA filing? I think they strung it out to the last possible moment because this company is on life support. I assume that you bozos always create these pseudo id's because you're ashamed of all the garbage you've posted under your real id's. By the way, what is your real id?
Well, compared to the rest of the responses, it's at least rational. It has taken Linzess, with a much superior drug (no nausea), hundreds of millions of dollars and more than three years to seize the dominant market share in both CIC and IBS-C from Amitiza. (Actually, I'm not sure how widely prescribed Amitiza was for IBS-C.) They are in Phase III trials for the 72mg dose for pediatric use. Here is what is far fetched: That without an immediate injection of serious amounts of cash, Synergy can do anything. This would have to come via a buyout or partnership. Ironwood had major partnerships sewn up years in advance. Why does Synergy have none?
Waiting for something substantive in the way of rebuttal, not more silly antics.
$14 in a few more months! Wow! Drop those shares and jump on those July 6 calls! One was traded for 40 cents Friday, but the bid is only a dime. Even if you get screwed and pay the full 40 cents, you will multiply your money 19 times when this reaches 14! Those stupid options MM's.